Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Mass Balance of [14C]PF-07799544 in Healthy Adult Males
NCT07578636Phase 1Completed
- Sponsor
- Pfizer
- Start
- May 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of polfurmetinib, sponsored by Pfizer. Primary endpoints: Total recovery (%) of radioactivity in urine, feces and vomitus and Metabolic profiling/identification and determination of relative abundance of [14C]PF-07799544 and metabolites. Started May 2026; status: completed.
02
Drugs
polfurmetinib
Beyond the preview
Go deeper on NCT07578636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07578636.